{
    "nctId": "NCT04899713",
    "briefTitle": "NEOZOL_Follow-up Study",
    "officialTitle": "Long-term Survival of Locally Advanced Breast Cancer Patients Treated With Neoadjuvant Chemotherapy With or Without Zoledronic Acid (ZOMETA\u00ae)",
    "overallStatus": "UNKNOWN",
    "conditions": "Locally Advanced Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Event-free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Woman who signed a written consent, included and randomised in the main analysis of the NEOZOL study\n\nExclusion Criteria:\n\n* Patient's opposition to the use of her data in this study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}